MYC Gene Amplification Frequently Observed in Stomach and Gastroesophageal Junction Cancers, Associated with Male Gender and Diminished Neoadjuvant Treatment Efficacy - Poll - MDSpire

MYC Gene Amplification Frequently Observed in Stomach and Gastroesophageal Junction Cancers, Associated with Male Gender and Diminished Neoadjuvant Treatment Efficacy

  • By

  • Ole Biegler

  • Hans-Michael Behrens

  • Jochen Haag

  • Thomas Becker

  • Steffen Markus Heckl

  • Silke Lüschen

  • Christoph Röcken

  • April 24, 2026

  • 0 min

Share

Original Source(s)

MYC Gene Amplification Frequently Observed in Stomach and Gastroesophageal Junction Cancers, Associated with Male Gender and Diminished Neoadjuvant Treatment Efficacy

  • by Ole Biegler, Hans-Michael Behrens, Jochen Haag, Thomas Becker, Steffen Markus Heckl, Silke Lüschen, Christoph Röcken

  • April 24, 2026

Related Content

Myelodysplastic syndromes complicated by atypical Sweet syndrome: a brief research report

Beyond inhibition: harnessing the DRD2–VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer

Data requirements of an informative, directive, and preventive mobile health application for gastric cancer